66
Transcenta Holding Limited
6628.HK · HKSE
$0.88 +3.53% (+$0.03)
1M -20.18%
Market Cap ¥310.1M
P/E Ratio -
Div. Yield -
ROE 32.08%
Piotroski F-Score Weak
2/9Valuation
50 /100
Fair P/S 41.70x
P/B 0.50x
P/E N/A
Growth
0 /100
Declining Rev. growth 58.58%
Book val. growth 25.14%
EPS growth N/A
Profitability
8 /100
Weak Gross margin 23.15%
FCF margin 1,922.97%
Net margin 2,740.08%
Quality
0 /100
Poor ROIC 24.53%
Asset turnover 0.01x
ROE 32.08%
Debt
46 /100
Moderate Debt/Equity 0.20x
Int. coverage -67.44x
Current ratio 0.25x
Stability
47 /100
Moderate Beta -0.47x
Profitable years 0
Rev. volatility 22.49%
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre 6628.HK
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Xueming Qian
Employees
155
Headquarters
Suzhou
Evenimente viitoare
31 MAR.
Earnings
Upcoming earnings report